Suchergebnisse - "d'Arminio Monforte, Antonella"

PubPharm (14)

1

Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia : A Randomized Clinical Trial

enthalten in: JAMA network open | 2021

von Menichetti, F. | Popoli, P. | Puopolo, M. | +107

ErratumIn: JAMA Netw Open. 2021 Dec 1;4(12):e2144236. - PMID 34932111

2

The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis : Findings From a Randomized Study

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2019

von Rossetti, B. | Gagliardini, R. | Sterrantino, G. | +20

3

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2) : week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

enthalten in: Lancet (London, England) | 2019

von Cahn, P. | Madero, J. | Arribas, J. | +118

CommentIn: Lancet. 2019 Jan 12;393(10167):106-108. - PMID 30420122

4

Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir-Ritonavir Plus Either Raltegravir or Tenofovir-Emtricitabine : A Substudy of the NEAT001/ANRS143 Trial

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2017

von Winston, A. | Stöhr, W. | Antinori, A. | +13

5

Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy : 48-week results of a randomized trial

enthalten in: PloS one | 2017

von Rossetti, B. | Gagliardini, R. | Meini, G. | +28

6

Atazanavir/ritonavir monotherapy : 96 week efficacy, safety and bone mineral density from the MODAt randomized trial

enthalten in: The Journal of antimicrobial chemotherapy | 2016

von Galli, L. | Spagnuolo, V. | Bigoloni, A. | +55

7

Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens : results from the MoLo study

enthalten in: The new microbiologica | 2014

von Gianotti, N. | Poli, A. | Galli, M. | +11

8

Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression : 48-week efficacy and safety results

enthalten in: AIDS (London, England) | 2014

von Castagna, A. | Spagnuolo, V. | Galli, L. | +46

9

Comparative effectiveness of initial antiretroviral therapy regimens : ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2011

von Mugavero, M. | May, M. | Ribaudo, H. | +68

10

Once-a-day (QD) vs. twice-daily (BID) nevirapine as simplification in PI-treated patients after 2 mos. of BID induction

enthalten in: Current HIV research | 2011

von Maserati, R. | Brandolini, M. | Cattelan, A. | +29